Wall Street is facing a rare test of capital. The company, which is expected to list on Nasdaq in the middle of this month under the ticker $ANTHROPIC , lowered its fully diluted valuation in its latest prospectus to $1.4 trillion, down 30% from the previously rumored $2 trillion. Behind this willingness to accept a lower valuation lies the real tension between the enormous, unavoidable cost of computing power and revenue growth, which has slowed from doubling in an earlier period to 47%. As this massive fundraising siphons liquidity from traditional U.S. equity markets, global macro assets are facing a subtle shift in risk appetite. Every fluctuation in the dollar and interest rates is influencing how capital moves among U.S. tech giants, gold, and crypto assets. Faced with an IPO of this scale, traditional asset managers are compelled by index allocation rules to buy shares passively, creating an implicit capital-squeezing effect on other high-risk assets. As AI-sector capital expenditure bills continue to mount, the market’s approach to pricing risk assets is shifting from pure narrative-driven exuberance toward a more cautious assessment of cash flows and actual returns. These cross-market capital flows and the transmission of sentiment will directly determine how well the broader risk-asset sector can absorb selling pressure in the period ahead, while every slight fluctuation in trading is testing investors’ defenses at the edge of tightening liquidity.